|1.||Palumbo, Antonio: 59 articles (08/2015 - 01/2004)|
|2.||Anderson, Kenneth C: 38 articles (07/2013 - 04/2002)|
|3.||Boccadoro, Mario: 33 articles (10/2014 - 01/2004)|
|4.||Figg, William D: 29 articles (04/2010 - 02/2002)|
|5.||Cavo, Michele: 28 articles (12/2014 - 03/2002)|
|6.||Rajkumar, S Vincent: 27 articles (09/2015 - 11/2002)|
|7.||Barlogie, Bart: 25 articles (06/2013 - 04/2002)|
|8.||Musto, Pellegrino: 24 articles (10/2014 - 04/2002)|
|9.||Bringhen, Sara: 24 articles (10/2014 - 01/2004)|
|10.||Richardson, Paul G: 24 articles (08/2014 - 06/2002)|
01/01/2015 - "Thalidomide is highly effective against multiple myeloma, but some patients must discontinue this medication due to adverse effects. "
06/01/2004 - "Thalidomide has demonstrated a remarkable efficacy in the treatment of multiple myeloma but its use may cause several toxicities. "
01/01/2004 - "s-Thalidomide has proven efficacy in multiple myeloma. "
01/01/2003 - "Thalidomide is presently used in therapy of patients with resistant and relapsed multiple myeloma with very promising results."
01/01/2002 - "Thalidomide has recently proven to be a useful drug for treatment of refractory and relapsed multiple myeloma patients, up to 35% of whom achieve remission. "
11/01/2009 - "Thalidomide alone delayed tumor growth, but the combination of thalidomide with OncdSyn appeared to produce the best results."
02/01/2008 - "Thalidomide administered orally in combination with SBE7betaCD, led to a significant delay in tumor formation as a result of improved cellular drug absorption, distribution through solubilization in experimental animals. "
11/21/2006 - "Thalidomide was significantly more likely to be effective in tumors smaller than 5 cm (PR + SD: 63.6% vs PD: 25.8%, P = 0.034 < 0.05). "
10/01/2001 - "The administration of thalidomide, which was suggested to be beneficial in the treatment of human cancers, had no substantial clinical effect on our patient. "
07/01/2003 - "However, thalidomide has been established to be useful in the treatment of various diseases including cancer. "
|3.||Crohn Disease (Crohn's Disease)
05/01/2001 - "In open-label trials, thalidomide has demonstrated efficacy in patients with refractory Crohn's disease; however, the therapeutic potential of thalidomide may be severely limited by the high incidence of drug-induced side effects. "
03/01/2015 - "Several open-label and retrospective studies have indicated that thalidomide may be beneficial in patients with refractory Crohn's disease (CD). "
01/01/2005 - "The results show that both APA and AC capsules allow for successful delivery of thalidomide in the gut and could prove beneficial in the treatment of Crohn's disease. "
08/01/2015 - "In a randomized controlled trial, thalidomide has shown to be effective in refractory Crohn's disease in children. "
11/27/2013 - "To determine whether thalidomide is effective in inducing remission in refractory pediatric Crohn disease. "
08/01/1976 - "Reactive episodes continue to be a serious complication, but the availability of thalidomide to control erythema nodosum leprosum has markedly improved the prognosis. "
04/01/2010 - "Thalidomide (Thal) provides effective treatment for erythema nodosum leprosum (ENL). "
12/15/2005 - "Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation."
10/20/2001 - "In 1964 it was discovered that thalidomide was effective against erythema nodosum leprosum. "
03/01/1998 - "The efficacy of thalidomide in the treatment of erythema nodosum leprosum is a well established fact; there is also accumulating evidence of its therapeutic value in a number of other inflammatory and immune-mediated conditions. "
|5.||Leprosy (Hansen's Disease)
02/01/2007 - "As expected, overall, thalidomide proved to be more effective in the treatment of type II leprosy reaction. "
10/01/2009 - "In this study, comparisons were made regarding the plasma concentrations of thalidomide in patients with ENL on the course or after leprosy therapy in a prospective clinical trial. "
10/01/1986 - "Thalidomide in leprosy--study of 94 cases."
10/01/1969 - "Motor conduction velocity studies in patients with leprosy reaction treated with thalidomide and other drugs."
10/01/1968 - "Trials with thalidomide derivatives in leprosy reactions."
|2.||lenalidomide (CC 5013)
|7.||Proteasome Endopeptidase Complex (Proteasome)
|8.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|9.||Adrenal Cortex Hormones (Corticosteroids)
|1.||Drug Therapy (Chemotherapy)
|2.||Stem Cell Transplantation
|3.||Bone Marrow Transplantation (Transplantation, Bone Marrow)